Resolvin D5, a Lipid Mediator, Inhibits Production of Interleukin-6 and CCL5 Via the ERK-NF-κB Signaling Pathway in Lipopolysaccharide-Stimulated THP-1 Cells

• Published in: Journal of microbiology and biotechnology Vol. 30; no. 1; pp. 85 - 92
• Main Authors: Chun, Hyun-Woo, Lee, Jintak, Pham, Thu-Huyen, Lee, Jiyon, Yoon, Jae-Hwan, Lee, Jin, Oh, Deok-Kun, Oh, Jaewook, Yoon, Do-Young
• Format: Journal Article
• Language: English
• Published: Korea (South) Korean Society for Microbiology and Biotechnology 28-01-2020; 한국미생물·생명공학회
• Subjects: Anti-Inflammatory Agents - pharmacology; Cell Survival - drug effects; Chemokine CCL5 - biosynthesis; Docosahexaenoic Acids - pharmacology; Down-Regulation; Humans; Inflammation; Interleukin-6 - biosynthesis; Lipopolysaccharides; MAP Kinase Signaling System - drug effects; Monocytes - drug effects; Phosphorylation - drug effects; Research article; Signal Transduction - drug effects; THP-1 Cells; 생물학; THP-1 cells; anti-inflammatory; NF-κB; Resolvin D5; ERK
• ISSN: 1017-7825; 1738-8872
• DOI: 10.4014/jmb.1907.07033

One of the omega-3 essential fatty acids, docosahexaenoic acid (DHA), is a significant constituent of the cell membrane and the precursor of several potent lipid mediators. These mediators are considered to be important in preventing or treating several diseases. Resolvin D5, an oxidized lipid mediator derived from DHA, has been known to exert anti-inflammatory effects. However, the detailed mechanism underlying these effects has not yet been elucidated in human monocytic THP-1 cells. In the present study, we investigated the effects of resolvin D5 on inflammation-related signaling pathways, including the extracellular signal-regulated kinase (ERK)-nuclear factor (NF)-κB signaling pathway. Resolvin D5 downregulated the production of interleukin (IL)-6 and chemokine (C-C motif) ligand 5 (CCL5). Additionally, these inhibitory effects were found to be modulated by mitogen-activated protein kinase (MAPK) and NF-κB in lipopolysaccharide (LPS)-treated THP-1 cells. Resolvin D5 inhibited the LPS-stimulated phosphorylation of ERK and translocation of p65 and p50 into the nucleus, resulting in the inhibition of IL-6 and CCL5 production. These results revealed that resolvin D5 exerts anti-inflammatory effects in LPS-treated THP-1 cells by regulating the phosphorylation of ERK and nuclear translocation of NF-kappaB.